HighTower Advisors’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-750
Closed -$50K 3084
2021
Q2
$50K Sell
750
-596
-44% -$39.7K ﹤0.01% 2845
2021
Q1
$165K Buy
+1,346
New +$165K ﹤0.01% 2647
2020
Q4
Sell
-1,448
Closed -$175K 2609
2020
Q3
$175K Buy
1,448
+212
+17% +$25.6K ﹤0.01% 2106
2020
Q2
$152K Buy
+1,236
New +$152K ﹤0.01% 2023